360045-08-5 Usage
Derivative of indole
Heterocyclic organic compound found in various plants
3,5-dimethylphenyl group
Aromatic group consisting of a phenyl ring with two methyl groups at the 3rd and 5th positions
Methoxy substituent
An oxygen atom bonded to a methyl group, attached at the 5th position of the indole ring
Serotonin receptor agonist
Has the potential to activate serotonin receptors, which are proteins that bind to the neurotransmitter serotonin
Synthesis of pharmaceuticals and natural products
The compound can be used as a building block or intermediate in the production of other medicinal or naturally occurring compounds
Biological and medicinal properties
Possesses potential for therapeutic applications, such as treating neurological disorders and cancer
Check Digit Verification of cas no
The CAS Registry Mumber 360045-08-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,6,0,0,4 and 5 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 360045-08:
(8*3)+(7*6)+(6*0)+(5*0)+(4*4)+(3*5)+(2*0)+(1*8)=105
105 % 10 = 5
So 360045-08-5 is a valid CAS Registry Number.
360045-08-5Relevant articles and documents
Palladium-catalyzed direct and regioselective C-H bond functionalization/ oxidative acetoxylation of indoles
Choy, Pui Ying,Lau, Chak Po,Kwong, Fuk Yee
supporting information; experimental part, p. 80 - 84 (2011/03/22)
The first general examples of palladium-catalyzed direct and selective oxidative C3-acetoxylation of indoles are presented. The mild reaction conditions (70 °C and with weak base, KOAc) in this indole C-H-acetoxylation are notable.
Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide
Sano, Hiroko,Noguchi, Tomomi,Tanatani, Aya,Hashimoto, Yuichi,Miyachi, Hiroyuki
, p. 3079 - 3091 (2007/10/03)
A series of substituted indoline and indole derivatives with cyclooxygenase (COX)-inhibitory activity was prepared during our structural development studies based on thalidomide as a multi-template lead compound. Structure-activity relationship studies in
A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles [2]
Klapars,Antilla,Huang,Buchwald
, p. 7727 - 7729 (2007/10/03)
-
